thumbnail_EVA Pharma Drives mRNA Vaccine website copy 1.jpg

EVA Pharma’s roots stretch back over a hundred years.

thumbnail_Pharmacy.jpeg

Pharmacy.jpeg

Our History

Our experienced leadership team keeps us on track.

thumbnail_Find_Out_More_Leaders.png

Find_Out_More_Leaders.png

Meet our Leaders

EVA Pharma’s success is based on its dynamic team, Our people are our power.

thumbnail_1704997569480.jfif

1704997569480.jfif

Life at EVA Pharma

A one-year technical support between EVA Pharma and PATH aims to empower local vaccine innovation and development technology.&nbsp;
&nbsp;
CAIRO, 3&nbsp;February 2025—<a id="menur4sd" class="fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn" title="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3735678-1&amp;h=1130473503&amp;u=http%3a%2f%2fwww.evapharma.com%2f&amp;a=eva+pharma" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3735678-1&amp;h=1130473503&amp;u=http%3A%2F%2Fwww.evapharma.com%2F&amp;a=EVA+Pharma" target="_blank" rel="noreferrer noopener" aria-label="Link EVA Pharma">EVA Pharma</a>, one of the fastest-growing healthcare organizations in the Middle East and Africa, announced today a new initiative to boost mRNA vaccine innovation and development in Africa. Supported by a one-year of technical advisory provided by PATH, an innovative global nonprofit organization dedicated to health equity, the initiative emphasizes EVA Pharma’s profound commitment to fostering Africa’s health resilience.&nbsp;&nbsp;
&nbsp;
EVA Pharma’s vaccine initiative, taking place at EVA Pharma’s mRNA Innovation Hub, has four focus areas, including refining lipid nanoparticle (LNP) formulations to reach stable LNP formulations for storage at 2°C–8°C, utilizing advanced lipids and in-house-developed polymers to enhance vaccine thermostability, advancing self-amplifying RNA (saRNA) and circular RNA (circRNA) encapsulation methods, and conducting robust safety and efficacy preclinical studies. As part of this research, experts from PATH, will conduct regular meetings with EVA Pharma’s research team to provide technical advisory support on the ongoing mRNA vaccine research, development, and production over a 12-month period.&nbsp;
&nbsp;
“We are bold in our ambition for Africa, establishing a sustainable vaccine development and manufacturing base that prioritizes the continental needs,” said Riad Armanious, CEO of EVA Pharma. “Despite innovation being a higher-risk bet, we will work with PATH to intensify our scientific knowledge, ensuring that vulnerable populations are protected throughout Africa.”&nbsp;
&nbsp;
About EVA Pharma’s mRNA Innovation Hub&nbsp;
EVA Pharma has notably focused on localizing innovation in recent years through investing in research infrastructure and financing. The company has established an in-house research and development footprint, including its mRNA Innovation Hub, which is fully equipped to handle the complete mRNA vaccine development lifecycle—from digital sequencing to final drug formulation. This includes antigen selection, protein engineering, mRNA construct design, process development, innovative formulation delivery systems, and analytical method development.&nbsp;&nbsp;
&nbsp;
Anticipated impact for EVA Pharma’s mRNA Innovation Hub in Africa&nbsp;
EVA Pharma’s mRNA Innovation Hub in Africa is poised to make a transformative impact on the continent’s healthcare and economic resilience. Since the research and development lab became operational in August 2024, EVA Pharma has been on track to establish a fully functional and end-to-end mRNA vaccine manufacturing facility by the end of 2025, with an anticipated annual capacity of 100 million vials. This initiative aligns with the Africa CDC’s goal of meeting 60% of the continent’s vaccine needs locally by 2040, which addresses a critical gap, as Africa currently produces less than 1% of its vaccines. By enhancing Africa’s ability to develop and manufacture vaccines locally, EVA Pharma supports health systems’ resilience and public health security, while also aligning with the African Vaccine Manufacturing Accelerator (AVMA) initiative, which was launched by Gavi in June 2024.&nbsp;&nbsp;
--end of release--&nbsp;
&nbsp;
&nbsp;
About EVA Pharma&nbsp;
EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biologic products.&nbsp;
&nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies.&nbsp;
&nbsp;
Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand.&nbsp;
&nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide.&nbsp;
&nbsp;
For more information, please visit: <a id="menur4sf" class="fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn" title="http://www.evapharma.com/" href="http://www.evapharma.com/" target="_blank" rel="noreferrer noopener" aria-label="Link www.evapharma.com">www.evapharma.com</a> &amp; <a id="menur4sh" class="fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn" title="https://www.evapharma.com/newsroom" href="https://www.evapharma.com/newsroom" target="_blank" rel="noreferrer noopener" aria-label="Link https://www.evapharma.com/newsroom">https://www.evapharma.com/newsroom</a> or follow us on <a id="menur4sj" class="fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn" title="https://www.facebook.com/evapharma/" href="https://www.facebook.com/Evapharma/" target="_blank" rel="noreferrer noopener" aria-label="Link Facebook">Facebook</a>, <a id="menur4sl" class="fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn" title="https://www.linkedin.com/company/eva-pharma/" href="https://www.linkedin.com/company/eva-pharma/" target="_blank" rel="noreferrer noopener" aria-label="Link LinkedIn">LinkedIn</a> &amp; <a id="menur4sn" class="fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn" title="https://www.instagram.com/eva.pharma/" href="https://www.instagram.com/eva.pharma/" target="_blank" rel="noreferrer noopener" aria-label="Link Instagram">Instagram</a>&nbsp;

Press Release

EVA Pharma Drives mRNA Vaccine Research & Development in Africa

EVA Pharma Drives mRNA Vaccine Research & Development in Africa

02 Feb, 2025

EVA Pharma Drives mRNA Vaccine Research & Development in Africa

02 Feb, 2025

Find out more about EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our experienced leadership team keeps us on track.

EVA Pharma’s success is based on its dynamic team, Our people are our power.

© 2026 Eva Pharma All Rights Reserved - شركة ايفا فارما للادوية و المستلزمات الطبية